SS
ARCT icon

SBI Securities’s Arcturus Therapeutics ARCT Stock Holding History

SBI Securities’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.19K Buy
921
+524
+132% +$4.13K ﹤0.01% 2084
2026
Q1 		$3.06K Buy
397
+198
+99% +$1.45K ﹤0.01% 2246
2025
Q4 		$1.22K Sell
199
-428
-68% -$4.62K ﹤0.01% 2570
2025
Q3 		$11.6K Buy
627
+545
+665% +$8.76K ﹤0.01% 1705
2025
Q2 		$1.07K Buy
82
+18
+28% +$213 ﹤0.01% 2652
2025
Q1 		$678 Buy
64
+1
+2% +$16 ﹤0.01% 2744
2024
Q4 		$1.07K Buy
+63
New +$1.19K ﹤0.01% 2571

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SBI Securities's ARCT Position: Q2 2026 in Review

SBI Securities increased its Arcturus Therapeutics (ARCT) stake by 132% in Q2 2026, buying an estimated $4.13K and bringing the position to 921 shares worth $6.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

SBI Securities first reported a position in ARCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.6K in Q3 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • SBI Securities held 921 shares of Arcturus Therapeutics worth $6.19K as of Q2 2026.
  • SBI Securities bought 524 Arcturus Therapeutics shares in Q2 2026, an estimated $4.13K.
  • Arcturus Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2084 holding.
  • SBI Securities first reported a position in Arcturus Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Arcturus Therapeutics position peaked at $11.6K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.